Table 1.
Somatic characteristics and medical qualification of study participants (mean ± SD).
| Variables | Total | RUN | UTR | p Value |
|---|---|---|---|---|
| Body height (cm) | 171.95 ± 7.87 | 175.20 ± 6.37 | 168.70 ± 8.17 | 0.06 |
| Body mass (kg) | 76.96 ± 7.16 | 76.33 ± 6.32 | 77.59 ± 8.21 | 0.70 |
| Total body fat (%) | 23.87 ± 5.35 | 21.33 ± 4.36 | 26.40 ± 5.20 | 0.01 |
| Body mass index (kg/m2) | 26.08 ± 2.20 | 24.87 ± 1.28 | 27.28 ± 2.32 | 0.01 |
| Erythrocytes (106/µL) | 4.84 ± 0.48 | 4.75 ± 0.55 | 4.93 ± 0.41 | 0.42 |
| Haemoglobin (g/dL) | 14.85 ± 1.20 | 14.52 ± 1.17 | 15.18 ± 1.19 | 0.23 |
| Haematocrit (%) | 43.36 ± 3.21 | 42.47 ± 3.02 | 44.25 ± 3.30 | 0.22 |
| ESR (mm/h) | 8.11 ± 7.56 | 6.70 ± 6.52 | 9.67 ± 8.69 | 0.41 |
| Leucocytes (103/µL) | 6.48 ± 1.49 | 6.31 ± 1.53 | 6.65 ± 1.51 | 0.62 |
| Platelets (103/µL) | 236.55 ± 53.73 | 242.10 ± 40.60 | 231.00 ± 66.16 | 0.29 |
| Fasting glucose (mg/dL) | 96.65 ± 9.07 | 93.31 ± 6.96 | 100.36 ± 10.06 | 0.09 |
| Glycated haemoglobin (%) | 5.30 ± 0.33 | 5.43 ± 0.13 | 5.17 ± 0.42 | 0.18 |
| TC (mg/dL) | 201.06 ± 39.29 | 206.15 ± 38.82 | 195.41 ± 41.43 | 0.57 |
| HDL (mg/dL) | 63.09 ± 16.94 | 70.73 ± 11.38 | 54.61 ± 18.60 | 0.03 |
| LDL (mg/dL) | 121.53 ± 34.38 | 119.45 ± 34.58 | 123.83 ± 36.09 | 0.79 |
| TG (mg/dL) | 82.98 ± 28.89 | 80.69 ± 28.50 | 85.52 ± 30.83 | 0.68 |
| AIP | 0.11 ± 0.22 | 0.04 ± 0.17 | 0.20 ± 0.24 | 0.11 |
| Total protein (g/L) | 71.57 ± 3.39 | 71.68 ± 3.98 | 71.45 ± 2.88 | 0.88 |
| Fibrinogen (g/L) | 2.71 ± 0.54 | 2.46 ± 0.57 | 2.97 ± 0.37 | 0.02 |
p < 0.05—significant differences active vs. inactive group; RUN: long distance runners, UTR: untrained—control group, ESR: erythrocyte sedimentation rate, TC: total cholesterol, HDL: high density lipoproteins, LDL: low density lipoproteins, TG: triglycerides, AIP: atherogenic index of plasma = log(TG/HDL).